(Q35965780)

11 August 2017

1 reference

title

Pharmacokinetics of antiretrovirals in pregnant women (English)

1 reference

11 August 2017

anti-retroviral agent

0 references

1 reference

1 reference

2

Edmund Capparelli

1 reference

11 August 2017

Mark Mirochnick

1

1 reference

11 August 2017

1 January 2004

1 reference

Clinical Pharmacokinetics

11 August 2017

1 reference

11 August 2017

43

1 reference

11 August 2017

15

1 reference

11 August 2017

1071-1087

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200443150-00002

11 August 2017

0 references

cites work

Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women

1 reference

12 December 2020

The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites

1 reference

12 December 2020

Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.

1 reference

12 December 2020

The maternal-fetal transfer of lamivudine in the ex vivo human placenta

1 reference

12 December 2020

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

1 reference

12 December 2020

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

12 December 2020

Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion.

1 reference

12 December 2020

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers

1 reference

12 December 2020

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi

1 reference

12 December 2020

Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules

1 reference

12 December 2020

Rapid gentamicin elimination in obstetric patients

1 reference

12 December 2020

Antidepressants during pregnancy and lactation: defining exposure and treatment issues

1 reference

12 December 2020

Management of human immunodeficiency virus infection in pregnancy

1 reference

12 December 2020

Plasma protein binding of drugs in pregnancy

1 reference

12 December 2020

Nelfinavir mesylate: a protease inhibitor

1 reference

12 December 2020

Nucleoside transport by perfused human placenta

1 reference

12 December 2020

Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

1 reference

12 December 2020

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

1 reference

12 December 2020

Pharmacokinetic disposition of zidovudine during pregnancy

1 reference

12 December 2020

Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound

1 reference

12 December 2020

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

1 reference

12 December 2020

Clinical pharmacokinetics of zidovudine. An overview of current data

1 reference

12 December 2020

Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

1 reference

12 December 2020

Interactions of various 19-nor steroids with human placental microsomal cytochrome P-450 (P-450hpm)

1 reference

12 December 2020

The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir

1 reference

12 December 2020

Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

12 December 2020

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team

1 reference

12 December 2020

Pharmacokinetics during pregnancy: evidence-based maternal dose formulation

1 reference

12 December 2020

Azidothymidine (zidovudine) transport by the human placenta

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

12 December 2020

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

12 December 2020

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

1 reference

12 December 2020

Induction of CYP2D6 in pregnancy

1 reference

12 December 2020

Myelomeningocele in a child with intrauterine exposure to efavirenz.

1 reference

12 December 2020

Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Pharmacokinetic changes during pregnancy and their clinical relevance

1 reference

12 December 2020

Intracellular carbovir triphosphate levels in patients taking abacavir once a day.

1 reference

12 December 2020

Drug disposition and pharmacokinetics in the maternal-placental-fetal unit

1 reference

12 December 2020

Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.

1 reference

12 December 2020

Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study

1 reference

12 December 2020

Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus

1 reference

12 December 2020

Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir

1 reference

12 December 2020

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

1 reference

12 December 2020

Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant women

1 reference

12 December 2020

Developmental pharmacology and toxicology of anti-HIV therapeutic agents: dideoxynucleosides.

1 reference

12 December 2020

Characterization of theophylline binding to serum proteins in pregnant and nonpregnant women

1 reference

12 December 2020

Pharmacokinetics of indinavir in HIV-positive pregnant women

1 reference

12 December 2020

Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission

1 reference

12 December 2020

The use of anticonvulsants during pregnancy

1 reference

12 December 2020

Transplacental passage of protease inhibitors at delivery

1 reference

12 December 2020

In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus

1 reference

12 December 2020

Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection

1 reference

12 December 2020

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

1 reference

12 December 2020

The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1.

1 reference

12 December 2020

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

1 reference

12 December 2020

Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy

1 reference

12 December 2020

Zidovudine Pharmacokinetics During Pregnancy

1 reference

12 December 2020

Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus

1 reference

12 December 2020

Serum protein binding of drugs during and after pregnancy in humans.

1 reference

12 December 2020

Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication

1 reference

12 December 2020

Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations

1 reference

12 December 2020

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

12 December 2020

Pharmacological implications of lengthened in-utero exposure to nevirapine

1 reference

12 December 2020

Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients

1 reference

12 December 2020

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

Induction of hepatic enzymes during normal human pregnancy

1 reference

12 December 2020

Drug disposition in mother and foetus

1 reference

12 December 2020

Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs

1 reference

12 December 2020

Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants

1 reference

12 December 2020

Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans

1 reference

12 December 2020

Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring

1 reference

12 December 2020

Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure

1 reference

12 December 2020

Zidovudine response relationships in early human immunodeficiency virus infection

1 reference

12 December 2020

Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women

1 reference

12 December 2020

CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acid

1 reference

12 December 2020

Multiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults

1 reference

12 December 2020

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

1 reference

12 December 2020

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Lopinavir protein binding in vivo through the 12-hour dosing interval

1 reference

12 December 2020

Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques

1 reference

12 December 2020

Concentrations of protease inhibitors in cord blood after in utero exposure

1 reference

12 December 2020

10.2165/00003088-200443150-00002

Identifiers

DOI

1 reference

PubMed ID

15568888

Dimensions Publication ID

11 August 2017

0 references

1 reference

PubMed ID

15568888